Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Heart Failure
Sort By
Newest First
1 / 1
1 / 1
Fast Track Designation
FDA Grants Fast Track Designation for Farxiga in Heart Failure
AstraZeneca
PR-M09-19-NI-042
Sep 18, 2019
FDA Approval
FDA Approves New Device to Improve Symptoms in Patients with Advanced Heart Failure
U.S. Food & Drug Administration
PR-M08-19-NI-055
Aug 20, 2019
FDA Fast Track
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
Eli Lilly and Company
PR-M06-19-NI-058
Jun 28, 2019
